PCR Biosystems Continues to Scale Up Operations to Ensure Ongoing Availability of COVID-19 Test Reagents
Product NewsPCR Biosystems Continues to Scale Up Operations to Ensure Ongoing Availability of COVID-19 Test ReagentsApr 03, 2020 by PCR BiosystemsUK company has the capacity to manufacture enough reagent daily for 4 million reactions—which is sufficient for millions of diagnostic tests